Sign inGet started

Chiniara Ellen

Insider CIK 1398764 · ALR General Counsel and Secretary · CMPX Director · KYMR Chief Legal Officer · ALXN EVP & General Counsel

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CMPX Compass Therapeutics, Inc. A Award deriv2026-01-022026-01-0590,000— $090,000SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2025-03-032025-03-0355,000— $055,000SEC↗
KYMR Kymera Therapeutics, Inc. A Award2025-03-032025-03-0327,500— $082,326SEC↗
KYMR Kymera Therapeutics, Inc. S Sale2025-03-032025-03-031,833$30.33 $55.6K80,493SEC↗
KYMR Kymera Therapeutics, Inc. S Sale2025-03-032025-03-03408$31.00 $12.6K80,085SEC↗
CMPX Compass Therapeutics, Inc. A Award deriv2025-02-112025-02-1340,000— $040,000SEC↗
KYMR Kymera Therapeutics, Inc. S Sale2025-01-062025-01-063,129$41.75 $130.6K54,826SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2024-03-012024-03-04130,531— $0130,531SEC↗
KYMR Kymera Therapeutics, Inc. A Award2024-03-012024-03-0421,755— $055,960SEC↗
CMPX Compass Therapeutics, Inc. A Award deriv2024-02-092024-02-1440,000— $040,000SEC↗
KYMR Kymera Therapeutics, Inc. S Sale2024-01-042024-01-053,295$22.58 $74.4K34,205SEC↗
CMPX Compass Therapeutics, Inc. A Award deriv2023-02-082023-02-0940,000— $040,000SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2023-01-032023-01-04225,000— $0225,000SEC↗
KYMR Kymera Therapeutics, Inc. A Award2023-01-032023-01-0437,500— $037,500SEC↗
CMPX Compass Therapeutics, Inc. A Award deriv2022-04-262022-04-2845,000— $045,000SEC↗
ALXN ALEXION PHARMACEUTICALS, I D To issuer2021-07-212021-07-23116,850— $00SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2021-07-142021-07-1627,657— $0116,850SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2021-07-142021-07-1626,812— $089,193SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2021-02-282021-03-0219,321— $062,381SEC↗
ALXN ALEXION PHARMACEUTICALS, I F Tax w/h2020-12-162020-12-182,988$157.96 $472.0K43,004SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2020-12-162020-12-1837,965— $062,917SEC↗
ALXN ALEXION PHARMACEUTICALS, I F Tax w/h2020-12-162020-12-1816,925$157.96 $2.67M45,992SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2020-12-152020-12-1856$95.53 $5.3K43,060SEC↗
ALXN ALEXION PHARMACEUTICALS, I F Tax w/h2020-03-022020-03-031,263$90.54 $114.4K24,898SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2020-02-282020-03-0310,200— $026,161SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2019-12-152020-03-0354$93.86 $5.1K24,952SEC↗
ALXN ALEXION PHARMACEUTICALS, I F Tax w/h2019-02-282019-03-04633$132.92 $84.1K7,711SEC↗
ALXN ALEXION PHARMACEUTICALS, I A Award2019-02-282019-03-058,250— $015,961SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award2018-02-282018-03-028,344— $08,344SEC↗
ALR ALERE INC. D To issuer deriv2017-10-032017-10-031,500— $00SEC↗
ALR ALERE INC. D To issuer deriv2017-10-032017-10-0319,470— $00SEC↗
ALR ALERE INC. D To issuer deriv2017-10-032017-10-0311,788— $00SEC↗
ALR ALERE INC. D To issuer deriv2017-10-032017-10-03975— $00SEC↗
ALR ALERE INC. D To issuer deriv2017-10-032017-10-035,250— $00SEC↗
ALR ALERE INC. D To issuer deriv2017-10-032017-10-0335,000— $00SEC↗
ALR ALERE INC. D To issuer deriv2017-10-032017-10-0310,000— $00SEC↗
ALR ALERE INC. D To issuer deriv2017-10-032017-10-035,000— $00SEC↗
ALR ALERE INC. D To issuer deriv2017-10-032017-10-038,331— $00SEC↗
ALR ALERE INC. D To issuer2017-10-032017-10-0332,764— $00SEC↗
ALR ALERE INC. M Exercise deriv2017-08-312017-09-056,667— $00SEC↗
ALR ALERE INC. F Tax w/h2017-08-312017-09-052,163$49.46 $107.0K32,764SEC↗
ALR ALERE INC. M Exercise2017-08-312017-09-056,667— $034,927SEC↗
ALR ALERE INC. M Exercise deriv2017-02-162017-02-212,500— $05,000SEC↗
ALR ALERE INC. M Exercise deriv2017-02-162017-02-217,236— $014,470SEC↗
ALR ALERE INC. F Tax w/h2017-02-162017-02-212,432$40.40 $98.3K28,260SEC↗
ALR ALERE INC. M Exercise2017-02-162017-02-217,236— $030,692SEC↗
ALR ALERE INC. F Tax w/h2017-02-162017-02-21811$40.40 $32.8K23,456SEC↗
ALR ALERE INC. M Exercise2017-02-162017-02-212,500— $024,267SEC↗
ALR ALERE INC. M Exercise deriv2016-10-142016-10-185,000— $00SEC↗
ALR ALERE INC. M Exercise deriv2016-10-142016-10-189,404— $00SEC↗
ALR ALERE INC. M Exercise deriv2016-10-142016-10-187,096— $00SEC↗
ALR ALERE INC. M Exercise deriv2016-10-142016-10-183,500— $07,096SEC↗
ALR ALERE INC. M Exercise2016-10-142016-10-183,500$37.74 $132.1K18,920SEC↗
ALR ALERE INC. F Tax w/h2016-10-142016-10-184,393$42.95 $188.7K21,529SEC↗
ALR ALERE INC. F Tax w/h2016-10-142016-10-188,263$42.95 $354.9K20,922SEC↗
ALR ALERE INC. M Exercise2016-10-142016-10-189,404$37.74 $354.9K29,185SEC↗
ALR ALERE INC. M Exercise2016-10-142016-10-185,000$37.74 $188.7K25,922SEC↗
ALR ALERE INC. F Tax w/h2016-10-142016-10-186,235$42.95 $267.8K19,781SEC↗
ALR ALERE INC. M Exercise2016-10-142016-10-187,096$37.74 $267.8K26,016SEC↗
ALR ALERE INC. M Exercise deriv2016-09-092016-09-136,667— $06,667SEC↗
ALR ALERE INC. M Exercise2016-09-092016-09-136,667— $015,420SEC↗
ALR ALERE INC. A Award deriv2016-02-162016-02-187,500— $07,500SEC↗
ALR ALERE INC. A Award deriv2016-02-162016-02-1821,706— $021,706SEC↗
ALR ALERE INC. J Other2015-12-312016-02-18232$33.23 $7.7K8,753SEC↗
ALR ALERE INC. M Exercise deriv2015-08-312015-09-026,666— $013,334SEC↗
ALR ALERE INC. M Exercise2015-08-312015-09-026,666— $010,687SEC↗
ALR ALERE INC. F Tax w/h2015-08-312015-09-022,166$51.97 $112.6K8,521SEC↗
ALR ALERE INC. J Other2015-06-302015-09-02270$31.84 $8.6K4,021SEC↗
ALR ALERE INC. A Award deriv2015-02-282015-03-0335,000— $035,000SEC↗
ALR ALERE INC. A Award deriv2015-02-252015-02-27250— $0250SEC↗
ALR ALERE INC. A Award deriv2015-02-252015-02-271,500— $01,500SEC↗
ALR ALERE INC. A Award deriv2014-08-312014-09-0320,000— $020,000SEC↗
ALR ALERE INC. A Award deriv2014-06-302014-07-025,000— $05,000SEC↗
ALR ALERE INC. A Award deriv2014-02-272014-03-0311,788— $011,788SEC↗
ALR ALERE INC. A Award deriv2013-02-072013-02-11975— $0975SEC↗